MétaCan
Menu
Back to cohort
Record W2792680700 · doi:10.1111/jce.13431

Mexiletine or catheter ablation after amiodarone failure in the VANISH trial

2018· article· en· W2792680700 on OpenAlexafffund
Marc W. Deyell, Christian Steinberg, Steve Doucette, Ratika Parkash, Isabelle Nault, Chris Gray, Vidal Essebag, Martin J. Gardner, Laurence D. Sterns, Jeff S. Healey, Tomasz Hruczkowski, Léna Rivard, Peter Leong‐Sit, Pablo B. Nery, John L. Sapp

Bibliographic record

VenueJournal of Cardiovascular Electrophysiology · 2018
Typearticle
Languageen
FieldMedicine
TopicCardiac Arrhythmias and Treatments
Canadian institutionsUniversity HospitalWestern UniversityUniversity of British ColumbiaMontreal Heart InstituteUniversity of OttawaMcGill University Health CentreHôpital du Sacré-Cœur de MontréalRoyal Jubilee HospitalUniversity of AlbertaQueen Elizabeth II Health Sciences CentrePopulation Health Research InstituteUniversité LavalDalhousie UniversityInstitut universitaire de cardiologie et de pneumologie de Québec
FundersBiosense WebsterCanadian Institutes of Health ResearchSt. Jude MedicalMichael Smith Health Research BC
KeywordsMedicineAmiodaroneMexiletineCatheter ablationCardiologyAblationInternal medicineAnesthesiaAtrial fibrillation

Abstract

fetched live from OpenAlex

INTRODUCTION: In patients with ischemic heart disease and ventricular tachycardia (VT) refractory to high dose amiodarone, the two most common therapeutic options are adjunctive mexiletine therapy or catheter ablation. There are little existing data on the efficacy of these strategies. We examined the relative efficacy of adjunctive mexiletine and catheter ablation among patients enrolled in the VANISH trial. METHODS: All subjects enrolled in the VANISH trial who had VT refractory to high dose (≥ 300 mg daily) amiodarone at baseline were included. Per protocol, subjects randomized to escalated drug therapy received adjunctive mexiletine. RESULTS: Nineteen of the 259 patients were receiving high-dose amiodarone at baseline and 11 were randomized to escalated therapy with mexiletine and 8 to ablation. The adjunctive mexiletine group had a higher rate of the primary composite outcome (death, VT storm, or appropriate shock) in comparison to catheter ablation (HR 6.87 [2.08-22.8]). Over 90% of the patients in the adjunctive mexiletine/group experienced a primary endpoint during a median 9.2 months' follow-up. There was no difference in the rate of adverse events between the two groups. CONCLUSIONS: Mexiletine has limited efficacy in the treatment of recurrent VT despite high-dose amiodarone therapy, in patients with ischemic heart disease. Catheter ablation is a superior strategy in this population.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Randomized trial · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.486
Threshold uncertainty score0.353

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0010.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.009
GPT teacher head0.257
Teacher spread0.248 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designRandomized trial
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations36
Published2018
Admission routes2
Has abstractyes

Explore more

Same venueJournal of Cardiovascular ElectrophysiologySame topicCardiac Arrhythmias and TreatmentsFrench-language works237,207